The European Union Drugs Agency (EUDA) today released its Consolidated Annual Activity Report 2025, capturing the agency’s key achievements, governance activities and organisational developments during the first full year of operation under its expanded mandate.Structured around three core areas — health, security and business transformation — the report outlines how the EUDA…
Čtěte více
This week, the European Union Drugs Agency (EUDA) hosted a technical meeting on Drug market-related violence in Europe: current situation, monitoring and responses, bringing together experts from across Europe to examine one of the most pressing security challenges linked to illicit drug markets today.Drug market-related violence has become an increasing concern in parts of Europe, fuelled by competition between criminal networks involved in the production, trafficking and distribution of illicit drugs. While the nature and intensity of this violence vary across countries, its…
Čtěte více
People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2026: Trends and Developments, released today (1).
Based on data from 29 countries (EU-27, Norway and Türkiye), the annual review highlights risks to public health posed by the wide availability and use of an increasingly diverse range of substances, often of high potency or purity. New cannabis products continue to appear, while the variety of opioids and stimulants sold is on the rise.…
Čtěte více
Today, the European Union Drugs Agency (EUDA) launches a public consultation to help shape its forthcoming Strategy 2030. The consultation forms part of a broader stakeholder engagement process supporting the development of the strategy, which will define the agency’s strategic priorities for the coming years.
The consultation seeks views on the future role of the agency, the…
Čtěte více
The latest patterns of injecting drug use in a selection of European cities are presented today in a new analysis from the European Union Drugs Agency (EUDA). The findings are from the agency’s ESCAPE project (1), which investigates the substances used by people who inject drugs (PWID) by chemically analysing the content of used syringes.
An estimated 500 000 people inject drugs in the EU, and they face elevated risks of overdose and infectious diseases. Reliable information on the substances being injected is essential to guide prevention strategies and the provision of harm reduction…
Čtěte více
The European Union Drugs Agency (EUDA) welcomed the Portuguese Minister of Health, Dra Ana Paula Martins, together with ICAD President Dra Joana Teixeira, to its premises today for discussions on evolving drug-related challenges in Europe and cooperation between Portugal and the EUDA.
The meeting, hosted by EUDA Executive Director Dr Lorraine Nolan, provided an opportunity to exchange views on current developments in the drug situation and on issues of relevance for both Portugal and the wider European context.
Experts from the EUDA presented the latest analysis of the drug situation in…
Čtěte více
Experts from across the EU Justice and Home Affairs Agencies’ Network (JHAAN) are meeting today for a thematic event examining how artificial intelligence (AI) can support innovation, preparedness and digital transformation across EU agencies.
Organised under the European Union Drugs Agency’s (EUDA) presidency of the JHAAN network, the hybrid meeting — AI in Action: JHAAN Journey from Strategy to Solutions — brings together specialists from a wide range of professional backgrounds, including IT, legal affairs, data protection, research, innovation and administration.
The event focuses on…
Čtěte více
